Disclosure 0001104659-26-105481-2

SEC FORM 4

$0.00

Addex Therapeutics Ltd. (ADXN)

Acquisition (code A) of 16,413,787 shares at $0 per share.

Reporting Person Dyer Timothy Mark · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code A

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001104659-26-105481 · filed 2026-09-04 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Addex Therapeutics Ltd. (ADXN)." Disclosed 2026-09-04. https://desqlong.com/cards/0001104659-26-105481-2 (retrieved 2026-09-26).